Arena Pharmaceuticals, Inc. (ARNA)
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
Recs
cashsage
(87.44)
Submitted: 11/8/2009 11:25:13 AM :
Start Price:
$3.49
ARNA Score:
+0.80
ARNA has a too high valuation compared to its sales potential. It is also one of the most loss making companies at least until 2011.
Moreover its stock price touched a low below 2.5 in April 2009.
Recs
earthunit
(53.54)
Submitted: 11/2/2009 7:12:55 PM :
Start Price:
$3.30
ARNA Score:
+0.88
Obesity drug sector about to catch fire. Room for several winners, just as there was with cholesterol drugs (statins).
Recs
TraderHater
(47.75)
Submitted: 10/30/2009 10:59:39 AM :
Start Price:
$3.64
ARNA Score:
+6.92
I lost 35 lbs in 3 months without drugs
Recs
stuinkc
(63.95)
Submitted: 10/26/2009 9:31:01 AM :
Start Price:
$4.50
ARNA Score:
-22.79
flavor of the months, pigs will try and gobble it up. pun intended
Recs
Merddin1
(32.65)
Submitted: 10/16/2009 1:46:40 AM :
Start Price:
$4.25
ARNA Score:
-18.28
Their new weight loss drug is in trial stage and is apparently effective. We know how crazy people are about losing weight.
Recs
Displacement
(81.10)
Submitted: 9/28/2009 4:39:29 PM :
Start Price:
$4.60
ARNA Score:
-26.44
Once it hits market, ARNA's obesity drug is going to be considered 'safer' than its 2 key competitors, despite the fact that it doesn't produce the same results. OREX and VVUS have already seen huge valuation improvement while ARNA has not- why?
Fewer side effects/no generic components/less aggressive results = safe prescription for a doctor treating a self-conscious fat guy.
Recs
libertybrewcity
(< 20)
Submitted: 9/10/2009 11:18:36 PM :
Start Price:
$5.37
ARNA Score:
-39.37
eh, new drug, some debt, not many sales, ill give it a few months to hit it big...
Recs
Brian7992
(< 20)
Submitted: 8/20/2009 7:40:30 AM :
Start Price:
$4.49
ARNA Score:
-31.67
Best Bio Bets
Recs
clawmann
(79.04)
Submitted: 8/12/2009 7:12:00 AM :
Start Price:
$4.35
ARNA Score:
-29.75
Bloom study will come out in a month or two. Strongly believe resukltswill be in line with the Blossom study results published a couple of months ago.
Recs
LimoDriver1971
(91.59)
Submitted: 7/29/2009 10:27:08 AM :
Start Price:
$4.91
ARNA Score:
-41.54
I have a sneaking suspicion that these obesity drug companies (especially the well managed ones) are going to go absolutely crazy if the health insurance reform goes through.
Especially after they outlaw being over-weight.
ARNA has certainly had it's share of ups and downs, but as the market swings towards losing weight this trend should level out and remain with an incline greater than that of the S&P
Recs
euphorbus
(92.91)
Submitted: 7/6/2009 8:02:47 PM :
Start Price:
$4.80
ARNA Score:
-49.44
Results from its second phase III trial of Arena's obesity drug should be positive, as was the first trial.
Recs
ddphillips05
(< 20)
Submitted: 6/30/2009 6:03:09 PM :
Start Price:
$4.95
ARNA Score:
-47.54
a diabetic drug and an althzeiers drug are perfect for the future
Recs
DogDayAftern00n
(71.10)
Submitted: 6/23/2009 10:18:37 PM :
Start Price:
$4.69
ARNA Score:
-47.11
BLOSSOM results coming out in September will more than likely send this stock upwards. This is a good bottom.
Recs
jeffsedlak
(< 20)
Submitted: 6/23/2009 6:55:15 PM :
Start Price:
$4.69
ARNA Score:
-47.11
LORCASERIN IS PROVING SAFE AND EFECTIVE
Recs
yomattus
(< 20)
Submitted: 6/23/2009 4:56:15 PM :
Start Price:
$4.69
ARNA Score:
-47.11
Lorcaserin will pass FDA approval for it's safety profile and will be combined with phentermine later to produce Lorphen. The safe version of fen phen. The market will be huge.
Recs
elifino
(40.26)
Submitted: 6/8/2009 5:46:32 PM :
Start Price:
$5.04
ARNA Score:
-47.13
Misunderstood information on this stock ? or Was it
on purpose ? Heavy Institutional Ownership + Insider
Buying + Unique Approach to Obesity Drug ( Lorc ) =
5 Bagger in a year or so.
Recs
FreeTutoringGrp
(96.27)
Submitted: 5/26/2009 10:45:38 AM :
Start Price:
$3.40
ARNA Score:
+18.58
looking for a pullback due to some profit taking
Recs
automaticaev
(80.81)
Submitted: 4/19/2009 3:50:38 AM :
Start Price:
$2.56
ARNA Score:
+7.85
drugs are good?
Recs
Bagbaguin
(96.66)
Submitted: 4/5/2009 3:21:56 PM :
Start Price:
$2.74
ARNA Score:
-4.52
Apr-05 @ $2.72 yahoo 1yr target: $6.36 huge upside!
Pharmaceuticals not as affected by recession & this one way over sold after obesity drug did not meed FDA benchmark.
Recs
Trimalerus
(99.67)
Submitted: 4/3/2009 7:39:41 PM :
Start Price:
$2.74
ARNA Score:
-4.52
As almost everyone knows we have a growing obesity problem in the US. This company is in late-stage trials of a new weight loss drug called Lorcaserin. Arena has been in a tailspin since trials of the drug failed to meet FDA benchmarks for effectiveness, Bio tech companies live or die based on clinical trials. Though the news is not as dire as the stock price would indicate. The FDA is still expected to pass the drug, because it has low side effects and can help people loose significant amounts of weight over time. To quote the recent article,"Analysts, overall, agree that the drug is poised for FDA approval." I think that this stock will recover in the long run, once people stop panicking...
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 93 1 2 3 4 5 Next »